Evidence map›Paper›PMID 29065903›Full record

Observational studyArthritis research & therapy2017

Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis.

Fiona M McQueen, Peter Chapman, Terina Pollock, Dena D'Souza, Arier C Lee, Nicola Dalbeth, Lisa Stamp, Karen Lindsay, Anthony Doyle

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Arthritis research & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Decoding adolescent TMJ osteoarthritis with multimodal machine learning.Journal of oral & facial pain and headache · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Fiona M McQueenDepartment of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand. f.mcqueen@auckland.ac.nz.
Peter ChapmanDepartment of Rheumatology, Immunology & Allergy, Christchurch Hospital, PO Box 4710, Christchurch, 8140, New Zealand.
Terina PollockDepartment of Radiology, Auckland City Hospital, 2 Park Rd, Grafton, Auckland, 1023, New Zealand.
Dena D'SouzaDepartment of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand.
Arier C LeeSection of Epidemiology & Biostatistics, School of Population Health (Tamaki Campus), University of Auckland, Auckland, 1142, New Zealand.
Nicola DalbethBone & Joint Research Group, Department of Medicine, The University of Auckland, Private Bag 92019, Auckland, New Zealand.
Lisa StampDepartment of Medicine, University of Otago, PO Box 4345, Christchurch, 8140, New Zealand.
Karen LindsayDepartment of Rheumatology, Greenlane Clinical Centre, Auckland District Health Board, 214 Green Lane West, Epsom, Auckland, 1051, New Zealand.
Anthony DoyleDepartment of Radiology, Auckland City Hospital, 2 Park Rd, Grafton, Auckland, 1023, New Zealand.
University of Auckland · NZAuckland City Hospital · NZAuckland District Health Board · NZChristchurch Hospital · NZGreenlane Clinical Centre · NZUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRheumatoid arthritis (RA) treat-to-target (T2T) regimens often use the disease activity score (28 joints) incorporating C-reactive protein (DAS28

methodsEighty seropositive RA patients with active disease were enrolled. Group A (N = 57) escalated to another conventional disease-modifying therapy (cDMARD) combination, and Group B (N = 23) to anti-TNF therapy/cDMARDs. Contrast-enhanced 3T-MRI wrist scans were obtained before and 4 months after regimen change. Scan pairs were scored for inflammation (MRI(i)) and damage. Disease activity was assessed using the DAS28

resultsEighty patients were enrolled and 66 MRI scan pairs were available for analysis. Intra-reader reliability was high: intraclass correlation coefficient (average) 0.89 (0.56-0.97). ΔDAS28

conclusionsWe report the first study investigating the link between changes in clinical and imaging inflammation in a real-world RA cohort escalating to conventional and biologic DMARDs. The association was significant but relatively weak, suggesting that MRI targets cannot yet be advocated as outcomes for T2T escalation.

trial registrationANZCTR 12614000895684 . Registered 22 August 2014.

Indexed as

AdalimumabAdultAgedAged, 80 and overAntirheumatic AgentsArthritis, RheumatoidC-Reactive ProteinDrug Therapy, CombinationFemaleHumansInflammationMagnetic Resonance ImagingMaleMiddle AgedOutcome Assessment, Health CareProspective StudiesAdalimumabAntirheumatic AgentsC-Reactive ProteinTumor Necrosis Factor-alpha

Identifiers

PMID29065903
PMCPMC5655857
OpenAlexW2766684240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.